サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：次世代シーケンシングインフォマティクスの世界市場 - 世界の産業規模、動向、競合、機会、予測、2018年～2028年
市場調査レポート
商品コード
1342707

次世代シーケンシングインフォマティクスの世界市場 - 世界の産業規模、動向、競合、機会、予測、2018年～2028年

Next Generation Sequencing Informatics Market-Global Industry Size, Share, Trends, Competition, Opportunity, & Forecast, 2018-2028 Segmented By Products & Services, Application, End User, Region

出版日
ページ情報
英文 114 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

次世代シーケンシングインフォマティクスの世界市場 - 世界の産業規模、動向、競合、機会、予測、2018年～2028年
出版日: 2023年08月01日
発行: TechSci Research
ページ情報: 英文 114 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の次世代シーケンシングインフォマティクス市場は、がんの有病率の増加と次世代シーケンシング（NGS）の臨床応用の増加により、予測期間2024年から2028年に目覚ましい成長が見込まれます。

Global Cancer Observatoryによると、2020年には世界中で約1,929万2,789件の新たながん症例が報告されました。乳がん、肺がん、大腸がん、前立腺がん、胃がんなどが2020年に報告されたがん症例の中で最も多いタイプでした。さらに、DNAシーケンシングのサンプル数の増加、次世代シーケンシング（NGS）インフォマティクスの使用によるDNAシーケンスのコスト削減、さまざまな政府の取り組み、臨床応用の増加、次世代シーケンシング（NGS）によるマイクロアレイ技術の代替は、市場成長に寄与するその他の要因です。

慢性疾患の有病率の上昇

世界的に、がんは死亡原因のトップです。世界保健機関（WHO）によると、過去5年間に世界中で約5,055万287件のがんが報告されています。これは、紫外線や電離放射線のような物理的発がん物質、アスベスト、タバコの煙、アルコール、アフラトキシン（食品汚染物質）、ヒ素（飲料水汚染物質）のような化学的発がん物質、寄生虫感染や不健康なライフスタイルの選択のような生物学的発がん物質の存在によるものです。現在、ヘルスケアにおける主要な問題はがんです。新規のがん治療に対する需要は、世界の次世代シーケンシングインフォマティクス市場の拡大に拍車をかけると予想されます。

同様に、HIV、ヒトパピローマウイルス、結核など、致命的で潜在的な治療法を必要とする新たなウイルス性疾患の流行の増加は、次世代シーケンシングインフォマティクスの世界市場の成長をさらに促進すると予想されます。2021年現在、世界全体で約3,840万人がHIVに感染しています。

次世代シーケンシング（NGS）のための臨床研究の増加

臨床研究は、観察研究と臨床試験の2つの要素からなる医学研究です。臨床研究活動は、次世代シーケンシング（NGS）を通じてウイルスゲノム配列を特定することにより、ヒトの健康管理につながります。次世代シーケンシング（NGS）技術は、ウイルスゲノムの変異とそれがヒトの健康にも及ぼす影響を研究する上で重要な役割を果たしています。Clinical OMICSに掲載された研究論文によると、2020年、コロナウイルスの約8万4,000のウイルスゲノム配列がGlobal Initiative to Share All Influenza Data（GISAID）にアップロードされました。さらに、全ゲノムおよびトランスクリプトームシーケンス、メタゲノミクスなどのアプリケーションは、さまざまな微生物サンプルの特性解析に使用されており、これが世界の次世代シーケンシング（NGS）インフォマティクス市場の成長を促進すると期待されています。

DNAマイクロアレイ技術の代替

最近の進歩とシーケンシングコストの急激な低下により、次世代シーケンシング（Next Generation Sequencing（NGS））の人気が急上昇しています。コストが高額でなくなり、方法がよりシンプルで広く普及するにつれて、研究者はゲノムアプリケーションの多くでマイクロアレイよりも次世代シーケンシング（NGS）を選択するようになっています。さらに、次世代シーケンシング（NGS）は、さらに高い解像度とゲノムの包括的なビューを提供する可能性を秘めています。

このことは、次世代シーケンシング（NGS）シーケンサーをヒトの健康治療に活用するために、世界中で多くの研究開発が行われていることを明確に示しており、それによって世界の次世代シーケンシング（NGS）インフォマティクス市場の成長を支えています。

利用可能なカスタマイズ

TechSci Research社は、所定の市場データを用いて、企業固有のニーズに応じたカスタマイズを提供しています。レポートでは以下のカスタマイズが可能です。

企業情報

  • 追加市場参入企業（最大5社）の詳細分析とプロファイリング

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の次世代シーケンシングインフォマティクスの市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品・サービス別（管理コンピューティングツール、商用データ解析・データ解釈・レポーティングツール、次世代シーケンシング（NGS）インフォマティクスサービス、ラボ情報管理システム（LIMS））
    • 用途別（創薬、遺伝子スクリーニング、疾病診断、その他）
    • エンドユーザー別（病院・診断センター、製薬・バイオテクノロジー企業、学術・研究機関）
    • 地域別（北米、欧州、アジア太平洋、南米、中東・アフリカ）
    • 企業別（2022年）
  • 市場マップ
    • 製品・サービス別
    • 用途別
    • エンドユーザー別
    • 地域別

第6章 北米の次世代シーケンシングインフォマティクス市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 製品・サービス別
    • 用途別
    • エンドユーザー別
    • 国別
  • 北米の国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の次世代シーケンシングインフォマティクス市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品・サービス別
    • 用途別
    • エンドユーザー別
    • 国別
  • 欧州の国別分析
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋の次世代シーケンシングインフォマティクスの市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品・サービス別
    • 用途別
    • エンドユーザー別
    • 国別
  • アジア太平洋の国別分析
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア

第9章 南米の次世代シーケンシングインフォマティクスの市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品・サービス別
    • 用途別
    • エンドユーザー別
    • 国別
  • 南米の国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの次世代シーケンシングインフォマティクス市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品・サービス別
    • 用途別
    • エンドユーザー別
    • 国別
  • 中東・アフリカの国別分析
    • アラブ首長国連邦
    • サウジアラビア
    • 南アフリカ
    • トルコ
    • エジプト

第11章 市場力学

  • 促進要因
    • 慢性疾患の有病率の上昇
    • 次世代シーケンシング（NGS）の臨床研究の増加
    • DNAマイクロアレイ技術の代替

第12章 課題

    • 次世代シーケンシング（NGS）実験を実施するための訓練を受けた臨床担当者の不足
    • 世界中で次世代シーケンシング（NGS）に対する償還率の低さ

第13章 市場動向と発展

第14章 競合情勢

  • Business Overview
  • Product Offerings
  • Recent Developments
  • Financials（As Reported）
  • Key Personnel
    • Abbott Laboratories, Inc.
    • F. Hoffmann-La Roche Ltd.
    • PerkinElmer, Inc.
    • SOPHiA GENETICS SA
    • Precigen, Inc.
    • QIAGEN N.V.
    • Illumina, Inc.
    • Agilent Technologies, Inc.
    • Eagle Genomics Limited
    • BGI Genomics Co., Ltd.

第15章 戦略的提言

目次
Product Code: 15017

Global Next Generation Sequencing (NGS) Informatics Market is anticipated to observe an impressive growth during the forecast period, 2024-2028 owing to growing prevalence of cancer and increase in clinical applications for Next Generation Sequencing (NGS). According to Global Cancer Observatory, in 2020, around 19,292,789 new cancer cases were reported worldwide. Breast Cancer, Lung Cancer, Colorectum Cancer, Prostate Cancer and Stomach Cancer were the most prevalent types of cancer cases reported in 2020. Additionally, increase in number of samples for DNA sequencing, reduced cost of DNA sequencing with the use of Next Generation Sequencing (NGS) informatics, various government initiatives, rising clinical applications, substitution of Microarray technology by Next Generation Sequencing (NGS) are other factors contributing to market growth.

The growing prevalence of new viral diseases has significantly increased the demand for Next Generation Sequencing (NGS) Informatics market. Additionally, growing research & development activities being initiated by various governments and pharmaceutical & biotechnology companies across the globe is further expected to create lucrative opportunities for the growth of Next Generation Sequencing (NGS) Informatics market in the coming years. In 2021, the research & development expenditure in the pharmaceutical industry across the globe was around USD238 billion.

Rise in Prevalence of Chronic Diseases

Globally, the cancer is the leading cause of death. According to World Health Organization, around 50,550,287 cases of cancer have been reported worldwide in the last five years. This is brought due to the presence of physical carcinogens like ultraviolet and ionising radiation, chemical carcinogens like asbestos, tobacco smoke, alcohol, aflatoxin (a food contaminant), and arsenic (a drinking water contaminant), and biological carcinogens like parasite infections and unhealthy lifestyle choices. A major issue in healthcare nowadays is cancer. The demand for novel cancer therapies is anticipated to fuel the expansion of the global Next Generation Sequencing (NGS) Informatics market.

Similarly, the increasing prevalence of new viral diseases such as HIV, Human Papillomavirus and Tuberculosis which are deadly and require a potential treatment is further expected to drive the growth of global Next Generation Sequencing (NGS) Informatics Market. As of 2021, globally around 38.4 million people were living with HIV.

Increase in Clinical Research for Next Generation Sequencing (NGS)

Clinical research is medical research constituting two components: observational studies, clinical trials. The clinical research activities result in taking care of the human health by identifying the viral genome sequence through Next Generation Sequencing (NGS). The Next Generation Sequencing (NGS) technique plays a vital role in studying the mutations in the viral genome and their impact on human health as well. According to a research article published in Clinical OMICS, 2020, approximately 84,000 viral genomic sequences of the coronavirus have been uploaded to the Global Initiative to Share All Influenza Data (GISAID). Additionally, the application like whole genome and transcriptome sequencing, metagenomics, etc. is used for the characterization of different microbial samples which in turn is expected to fuel the growth of Global Next Generation Sequencing (NGS) Informatics Market.

Substitution of DNA Microarray Technology

With recent advancements and a radical decline in sequencing costs, the popularity of next generation sequencing (Next Generation Sequencing (NGS)) has skyrocketed. As costs become less prohibitive and methods become simpler and more widespread, researchers are choosing Next Generation Sequencing (NGS) over microarrays for more of their genomic applications. Additionally, Next Generation Sequencing (NGS) has the potential to offer even higher resolution and a more comprehensive view of the genome.

This clearly indicates that a lot of R&D is being done across the globe for utilizing Next Generation Sequencing (NGS) sequencing for the treatment of human health, thereby supporting the growth of global Next Generation Sequencing (NGS) Informatics Market.

Market Segmentation

Global Next Generation Sequencing (NGS) Informatics Market can be segmented based on products & services, application, end user, region and competitional landscape. Based on products & services, the market can be categorized into storage and computing tools, commercial data analysis, data interpretation, and reporting tools, Next Generation Sequencing (NGS), laboratory information management systems (LIMS). Based on application, the market can be fragmented into drug discovery, genetic screening, disease diagnosis, and others. Based on end user, the market can be divided into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, academic and research institutions.

Company Profiles

Abbott Laboratories, Inc., F. Hoffmann-La Roche Ltd., PerkinElmer, Inc., SOPHiA GENETICS SA, Precigen, Inc., QIAGEN N.V., Illumina, Inc., Agilent Technologies, Inc., Eagle Genomics Limited, BGI Genomics Co., Ltd. are some of the key players operating in the Global Next Generation Sequencing (NGS) Informatics Market.

Report Scope

In this report, Global Next Generation Sequencing (NGS) Informatics Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Next Generation Sequencing (NGS) Informatics Market, By Products & Services:

  • Storage and Computing Tools
  • Commercial Data Analysis
  • Data Interpretation, and Reporting Tools
  • Next Generation Sequencing (NGS)
  • Laboratory Information Management Systems (LIMS)

Next Generation Sequencing (NGS) Informatics Market, By Application:

  • Drug Discovery
  • Genetic Screening
  • Disease Diagnosis
  • Others

Next Generation Sequencing (NGS) Informatics Market, By End User:

  • Hospitals and Diagnostic Centers
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutions

Next Generation Sequencing (NGS) Informatics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Turkey
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Next Generation Sequencing (NGS) Informatics Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Next Generation Sequencing (NGS) Informatics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Products & Services (Storage and Computing Tools, Commercial Data Analysis, Data Interpretation, and Reporting Tools, Next Generation Sequencing (NGS) Informatics Services, Laboratory Information Management Systems (LIMS))
    • 5.2.2. By Application (Drug Discovery, Genetic Screening, Disease Diagnosis, and Others)
    • 5.2.3. By End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Academic and Research Institutions)
    • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East, and Africa)
    • 5.2.5. By Company (2022)
  • 5.3. Market Map
    • 5.3.1. By Products & Services
    • 5.3.2. By Application
    • 5.3.3. By End User
    • 5.3.4. By Region

6. North America Next Generation Sequencing (NGS) Informatics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Products & Services
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Next Generation Sequencing (NGS) Informatics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Products & Services
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Next Generation Sequencing (NGS) Informatics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Products & Services
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Next Generation Sequencing (NGS) Informatics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Products & Services
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Next Generation Sequencing (NGS) Informatics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Products & Services
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Next Generation Sequencing (NGS) Informatics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Products & Services
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
        • 7.3.1.2.4. By Country
    • 7.3.2. France Next Generation Sequencing (NGS) Informatics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Products & Services
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Next Generation Sequencing (NGS) Informatics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Products & Services
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Next Generation Sequencing (NGS) Informatics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Products & Services
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Next Generation Sequencing (NGS) Informatics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Products & Services
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia-Pacific Next Generation Sequencing (NGS) Informatics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Products & Services
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Next Generation Sequencing (NGS) Informatics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Products & Services
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. Japan Next Generation Sequencing (NGS) Informatics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Products & Services
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. India Next Generation Sequencing (NGS) Informatics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Products & Services
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Next Generation Sequencing (NGS) Informatics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Products & Services
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Next Generation Sequencing (NGS) Informatics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Products & Services
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America Next Generation Sequencing (NGS) Informatics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Products & Services
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Next Generation Sequencing (NGS) Informatics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Products & Services
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Next Generation Sequencing (NGS) Informatics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Products & Services
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Next Generation Sequencing (NGS) Informatics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Products & Services
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa Next Generation Sequencing (NGS) Informatics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Products & Services
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. UAE Next Generation Sequencing (NGS) Informatics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Products & Services
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Next Generation Sequencing (NGS) Informatics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Products & Services
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. South Africa Next Generation Sequencing (NGS) Informatics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Products & Services
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User
    • 10.3.4. Turkey Next Generation Sequencing (NGS) Informatics Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Products & Services
        • 10.3.4.2.2. By Application
    • 10.3.5. Egypt Next Generation Sequencing (NGS) Informatics Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Products & Services
        • 10.3.5.2.2. By Application
        • 10.3.5.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
    • 11.1.1. Rise in Prevalence of Chronic Diseases
    • 11.1.2. Increase in clinical research for Next Generation Sequencing (NGS)
    • 11.1.3. Substitution of DNA Microarray Technology

12. Challenges

    • 12.1.1. Lack of trained clinical personnel for conducting Next Generation Sequencing (NGS) experiments
    • 12.1.2. Poor reimbursement rates for Next Generation Sequencing (NGS) across the globe

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Product Offerings
  • 14.3. Recent Developments
  • 14.4. Financials (As Reported)
  • 14.5. Key Personnel
    • 14.5.1. Abbott Laboratories, Inc.
    • 14.5.2. F. Hoffmann-La Roche Ltd.
    • 14.5.3. PerkinElmer, Inc.
    • 14.5.4. SOPHiA GENETICS SA
    • 14.5.5. Precigen, Inc.
    • 14.5.6. QIAGEN N.V.
    • 14.5.7. Illumina, Inc.
    • 14.5.8. Agilent Technologies, Inc.
    • 14.5.9. Eagle Genomics Limited
    • 14.5.10. BGI Genomics Co., Ltd.

15. Strategic Recommendations